{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:34:20Z","timestamp":1776188060321,"version":"3.50.1"},"reference-count":149,"publisher":"IOP Publishing","issue":"2","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"name":"The international cooperative project of the National Key R&D Program of China","award":["grant No. 2017YFE0126900"],"award-info":[{"award-number":["grant No. 2017YFE0126900"]}]},{"name":"Program of Shanghai Academic Research Leade","award":["18XD1400500"],"award-info":[{"award-number":["18XD1400500"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No.2018SHZDZX01"],"award-info":[{"award-number":["No.2018SHZDZX01"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pharmacotherapies for brain disorders are generally faced with obstacles from the blood-brain barrier (BBB). There are a variety of drug delivery systems that have been put forward to cross or bypass the BBB with the access to the central nervous system. Brain drug delivery systems have benefited greatly from the development of nanocarriers, including lipids, polymers and inorganic materials. Consequently, various kinds of brain drug delivery nano-systems have been established, such as liposomes, polymeric nanoparticles (PNPs), nanomicelles, nanohydrogels, dendrimers, mesoporous silica nanoparticles and magnetic iron oxide nanoparticles. The characteristics of their carriers and preparations usually differ from each other, as well as their transportation mechanisms into intracerebral lesions. In this review, different types of brain drug delivery nanocarriers are classified and summarized, especially their significant achievements, to present several recommendations and directions for future strategies of cerebral delivery.<\/jats:p>","DOI":"10.1088\/1748-605x\/abdc97","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T01:02:51Z","timestamp":1610931771000},"page":"024104","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Recent advances on drug delivery nanocarriers for cerebral disorders"],"prefix":"10.1088","volume":"16","author":[{"given":"Zheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2725","authenticated-orcid":false,"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"bmmabdc97bib1","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1039\/D0BM00809E","type":"journal-article","article-title":"Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases","volume":"8","author":"Masoudi Asil","year":"2020","journal-title":"Biomater. Sci."},{"key":"bmmabdc97bib2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1080\/17425247.2020.1810015","type":"journal-article","article-title":"Nanoparticle-mediated therapeutic compounds delivery to glioblastoma","volume":"17","author":"Gallego","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"bmmabdc97bib3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","type":"journal-article","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater. Today"},{"key":"bmmabdc97bib4","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801362","type":"journal-article","article-title":"Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"key":"bmmabdc97bib5","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700002","type":"journal-article","article-title":"Remote control of cellular functions: the role of smart nanomaterials in the medicine of the future","volume":"6","author":"Genchi","year":"2017","journal-title":"Adv. Healthcare Mater."},{"key":"bmmabdc97bib6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.01.012","type":"journal-article","article-title":"A window into the brain: tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders","volume":"148","author":"Samal","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmabdc97bib7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jconrel.2019.11.037","type":"journal-article","article-title":"Dual and multi-targeted nanoparticles for site-specific brain drug delivery","volume":"317","author":"Luo","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119292","type":"journal-article","article-title":"Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases","volume":"217","author":"Ballance","year":"2019","journal-title":"Biomaterials"},{"key":"bmmabdc97bib9","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000124","type":"journal-article","article-title":"Targeting glioblastoma: advances in drug delivery and novel therapeutic approaches","volume":"4","author":"Yeini","year":"2020","journal-title":"Adv. Ther."},{"key":"bmmabdc97bib10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902906","type":"journal-article","article-title":"A novel targeted and high-efficiency nanosystem for combinational therapy for Alzheimer\u2019s disease","volume":"7","author":"Yang","year":"2020","journal-title":"Adv. Sci."},{"key":"bmmabdc97bib11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejpb.2018.11.002","type":"journal-article","article-title":"Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents","volume":"133","author":"Musumeci","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"bmmabdc97bib12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","type":"journal-article","article-title":"Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders","volume":"11","author":"Lochhead","year":"2020","journal-title":"Front. Physiol."},{"key":"bmmabdc97bib13","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701921","type":"journal-article","article-title":"Drug delivery to the brain across the blood-brain barrier using nanomaterials","volume":"13","author":"Tsou","year":"2017","journal-title":"Small"},{"key":"bmmabdc97bib14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1049\/iet-nbt.2019.0351","type":"journal-article","article-title":"Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours","volume":"14","author":"Ebrahimi","year":"2020","journal-title":"IET Nanobiotechnol."},{"key":"bmmabdc97bib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183298","type":"journal-article","article-title":"Tight junction modulation at the blood-brain barrier: current and future perspectives","volume":"1862","author":"Hashimoto","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"bmmabdc97bib16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijpharm.2019.01.056","type":"journal-article","article-title":"Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier","volume":"559","author":"Sharma","year":"2019","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119582","type":"journal-article","article-title":"Transcellular brain drug delivery: a review on recent advancements","volume":"586","author":"Azarmi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","type":"journal-article","article-title":"Polymer-drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"bmmabdc97bib19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.brainresbull.2019.11.017","type":"journal-article","article-title":"Approaches for encephalic drug delivery using nanomaterials: the current status","volume":"155","author":"A","year":"2020","journal-title":"Brain Res. Bull."},{"key":"bmmabdc97bib20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2016.1208651","type":"journal-article","article-title":"Small endogenous molecules as moiety to improve targeting of CNS drugs","volume":"14","author":"Sutera","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"bmmabdc97bib21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","type":"journal-article","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"bmmabdc97bib22","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1021\/nn5003375","type":"journal-article","article-title":"Overcoming the blood\u2013brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"key":"bmmabdc97bib23","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/acschemneuro.9b00470","type":"journal-article","article-title":"Nanotechnology-based diagnostics and therapy for pathogen-related infections in the CNS","volume":"11","author":"Tamil Selvan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"bmmabdc97bib24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","type":"journal-article","article-title":"Applications of nanotechnology in drug delivery to the central nervous system","volume":"111","author":"Saeedi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"bmmabdc97bib25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jddst.2017.09.022","type":"journal-article","article-title":"Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders","volume":"43","author":"Md","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmabdc97bib26","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000118","type":"journal-article","article-title":"Nanomedicine revisited: next generation therapies for brain cancer","volume":"3","author":"Bhargav","year":"2020","journal-title":"Adv. Ther."},{"key":"bmmabdc97bib27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3109\/1061186X.2015.1058803","type":"journal-article","article-title":"Adenosine-associated delivery systems","volume":"23","author":"Kazemzadeh-Narbat","year":"2015","journal-title":"J. Drug Target."},{"key":"bmmabdc97bib28","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.xphs.2020.06.008","type":"journal-article","article-title":"Characterization of brain-targeted drug delivery enhanced by a combination of lipid-based microbubbles and non-focused ultrasound","volume":"109","author":"Omata","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"bmmabdc97bib29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.addr.2017.06.002","type":"journal-article","article-title":"Covalent nano delivery systems for selective imaging and treatment of brain tumors","volume":"113","author":"Ljubimova","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmabdc97bib30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2217\/nnm-2019-0443","type":"journal-article","article-title":"Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases","volume":"15","author":"Cano","year":"2020","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib31","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab8d6b","type":"journal-article","article-title":"The particle size of drug nanocarriers dictates the fate of neurons; critical points in neurological therapeutics","volume":"31","author":"Poormoghadam","year":"2020","journal-title":"Nanotechnology"},{"key":"bmmabdc97bib32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101628","type":"journal-article","article-title":"A comprehensive review of nano drug delivery system in the treatment of CNS disorders","volume":"57","author":"Asha Spandana","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmabdc97bib33","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ijbiomac.2019.10.238","type":"journal-article","article-title":"Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathies","volume":"153","author":"Ramadan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmabdc97bib34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.msec.2018.02.004","type":"journal-article","article-title":"Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine","volume":"92","author":"Zhao","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"bmmabdc97bib35","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110446","type":"journal-article","article-title":"Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice","volume":"183","author":"Du","year":"2019","journal-title":"Colloids Surf. B"},{"key":"bmmabdc97bib36","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.sjbs.2020.04.045","type":"journal-article","article-title":"The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model","volume":"27","author":"Almuhayawi","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"bmmabdc97bib37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117394","type":"journal-article","article-title":"Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer\u2019s, Parkinson\u2019s and Prion\u2019s","volume":"245","author":"Nirale","year":"2020","journal-title":"Life Sci."},{"key":"bmmabdc97bib38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jconrel.2020.06.038","type":"journal-article","article-title":"In vivo gene delivery mediated by non-viral vectors for cancer therapy","volume":"325","author":"Mohammadinejad","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801586","type":"journal-article","article-title":"Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci."},{"key":"bmmabdc97bib40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mehy.2017.01.026","type":"journal-article","article-title":"Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer\u2019s disease","volume":"101","author":"Chintamaneni","year":"2017","journal-title":"Med. Hypotheses"},{"key":"bmmabdc97bib41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.biomaterials.2018.12.027","type":"journal-article","article-title":"Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease","volume":"197","author":"Sun","year":"2019","journal-title":"Biomaterials"},{"key":"bmmabdc97bib42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.actbio.2020.03.021","type":"journal-article","article-title":"Self-assembled polydopamine nanoparticles improve treatment in Parkinson\u2019s disease model mice and suppress dopamine-induced dyskinesia","volume":"109","author":"Vong","year":"2020","journal-title":"Acta Biomater."},{"key":"bmmabdc97bib43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119148","type":"journal-article","article-title":"Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson\u2019s disease","volume":"579","author":"Bhattamisra","year":"2020","journal-title":"Int.J. Pharm."},{"key":"bmmabdc97bib44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","type":"journal-article","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"bmmabdc97bib45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101790","type":"journal-article","article-title":"Parkinson\u2019s disease: current drug therapy and unraveling the prospects of nanoparticles","volume":"58","author":"Paul","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmabdc97bib46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","type":"journal-article","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"bmmabdc97bib47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","type":"journal-article","article-title":"Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies","volume":"77","author":"Luna","year":"2020","journal-title":"JAMA Neurol."},{"key":"bmmabdc97bib48","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/jcm9020430","type":"journal-article","article-title":"Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases","volume":"9","author":"Salehi","year":"2020","journal-title":"J. Clin. Med."},{"key":"bmmabdc97bib49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41583-019-0126-4","type":"journal-article","article-title":"Neuron-glia interactions in the pathophysiology of epilepsy","volume":"20","author":"Patel","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"bmmabdc97bib50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","type":"journal-article","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"bmmabdc97bib51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jphotobiol.2018.05.003","type":"journal-article","article-title":"A facile approach for synthesis of nano-CeO2 particles loaded co-polymer matrix and their colossal role for blood-brain barrier permeability in cerebral ischemia","volume":"187","author":"Gao","year":"2018","journal-title":"J. Photochem. Photobiol. B"},{"key":"bmmabdc97bib52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104795","type":"journal-article","article-title":"Nose to brain drug delivery\u2014a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion","volume":"159","author":"Long","year":"2020","journal-title":"Pharmacol. Res."},{"key":"bmmabdc97bib53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119476","type":"journal-article","article-title":"Neuroprotection by curcumin: a review on brain delivery strategies","volume":"585","author":"Askarizadeh","year":"2020","journal-title":"Int.J. Pharm."},{"key":"bmmabdc97bib54","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","type":"journal-article","article-title":"Brain tumor microenvironment and host state: implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"bmmabdc97bib55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102039","type":"journal-article","article-title":"Targeted nano-drug delivery system for glioblastoma therapy: in vitro in vivo study","volume":"60","author":"Hassanzadeganroudsari","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmabdc97bib56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","type":"journal-article","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"bmmabdc97bib57","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","type":"journal-article","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"bmmabdc97bib58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.drudis.2019.10.005","type":"journal-article","article-title":"Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook","volume":"25","author":"Sabir","year":"2020","journal-title":"Drug Discovery Today"},{"key":"bmmabdc97bib59","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/c8cs00805a","type":"journal-article","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"bmmabdc97bib60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jconrel.2020.09.002","type":"journal-article","article-title":"Advances in drug delivery technology for the treatment of glioblastoma multiforme","volume":"328","author":"Cha","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib61","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/molecules22091401","type":"journal-article","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Palmerston Mendes","year":"2017","journal-title":"Molecules"},{"key":"bmmabdc97bib62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","type":"journal-article","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmabdc97bib63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","type":"journal-article","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin.B"},{"key":"bmmabdc97bib64","doi-asserted-by":"publisher","DOI":"10.1177\/2041731419897460","type":"journal-article","article-title":"Targeting with nanoparticles for the therapeutic treatment of brain diseases","volume":"11","author":"Jin","year":"2020","journal-title":"J. Tissue Eng."},{"key":"bmmabdc97bib65","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s11468-020-01206-7","type":"journal-article","article-title":"Transferrin-mediated glioblastoma cell targeting of hexagonal boron nitrides","volume":"15","author":"Emanet","year":"2020","journal-title":"Plasmonics"},{"key":"bmmabdc97bib66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","type":"journal-article","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib67","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.msec.2016.07.080","type":"journal-article","article-title":"Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: a review","volume":"69","author":"Mujokoro","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"bmmabdc97bib68","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.110638","type":"journal-article","article-title":"Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer","volume":"110","author":"de Melo","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"bmmabdc97bib69","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1021\/acsnano.7b00397","type":"journal-article","article-title":"Selective targeting of neurons with inorganic nanoparticles: revealing the crucial role of nanoparticle surface charge","volume":"11","author":"Dante","year":"2017","journal-title":"ACS Nano"},{"key":"bmmabdc97bib70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","type":"journal-article","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmabdc97bib71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120105","type":"journal-article","article-title":"Development of a peptide-based delivery platform for targeting malignant brain tumors","volume":"252","author":"Rahn","year":"2020","journal-title":"Biomaterials"},{"key":"bmmabdc97bib72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2017.10.024","type":"journal-article","article-title":"Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment","volume":"268","author":"Li","year":"2017","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bcp.2018.05.016","type":"journal-article","article-title":"Nano-delivery systems for encapsulation of dietary polyphenols: an experimental approach for neurodegenerative diseases and brain tumors","volume":"154","author":"Squillaro","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"bmmabdc97bib74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2019.03.010","type":"journal-article","article-title":"Dual-drug loaded nanoparticles of epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer\u2019s disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J. Control Release"},{"key":"bmmabdc97bib75","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.cclet.2017.06.024","type":"journal-article","article-title":"Development and application of nano-flavor-drug carriers in neurodegenerative diseases","volume":"28","author":"Ji","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"bmmabdc97bib76","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","type":"journal-article","article-title":"Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer\u2019s disease","volume":"148","author":"Akel","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"bmmabdc97bib77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2020.02.015","type":"journal-article","article-title":"Nanocarrier-mediated brain delivery of bioactives for treatment\/prevention of neurodegenerative diseases","volume":"321","author":"Babazadeh","year":"2020","journal-title":"J. Control Release"},{"key":"bmmabdc97bib78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jconrel.2020.07.012","type":"journal-article","article-title":"Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines","volume":"326","author":"Fattahi","year":"2020","journal-title":"J. Control Release"},{"key":"bmmabdc97bib79","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","type":"journal-article","article-title":"L-Type amino acid transporter 1 as a target for drug delivery","volume":"37","author":"Puris","year":"2020","journal-title":"Pharm. Res."},{"key":"bmmabdc97bib80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.05.082","type":"journal-article","article-title":"Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolism","volume":"124","author":"Zhao","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"bmmabdc97bib81","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpharm.2019.03.011","type":"journal-article","article-title":"Natural biodegradable polymers based nano-formulations for drug delivery: a review","volume":"561","author":"George","year":"2019","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib82","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","type":"journal-article","article-title":"Doxil(R)\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control Release"},{"key":"bmmabdc97bib83","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1124\/jpet.119.264127","type":"journal-article","article-title":"Dual-modified liposome for targeted and enhanced gene delivery into mice brain","volume":"374","author":"Dos Santos Rodrigues","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"bmmabdc97bib84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","type":"journal-article","article-title":"Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation","volume":"164","author":"Gaillard","year":"2012","journal-title":"J. Control Release"},{"key":"bmmabdc97bib85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3702518","type":"journal-article","article-title":"Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"key":"bmmabdc97bib86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","type":"journal-article","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib87","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","type":"journal-article","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Control Release"},{"key":"bmmabdc97bib88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2019.09.017","type":"journal-article","article-title":"Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier","volume":"519","author":"He","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"bmmabdc97bib89","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijpharm.2018.11.028","type":"journal-article","article-title":"Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles","volume":"554","author":"Ana","year":"2019","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib90","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111076","type":"journal-article","article-title":"Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: formulation; optimization and in-vivo evaluation","volume":"193","author":"Abdel Hady","year":"2020","journal-title":"Colloids Surf. B"},{"key":"bmmabdc97bib91","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2019.125328","type":"journal-article","article-title":"Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles","volume":"302","author":"Ban","year":"2020","journal-title":"Food Chem."},{"key":"bmmabdc97bib92","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","type":"journal-article","article-title":"SLN and NLC for topical, dermal, and transdermal drug delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"bmmabdc97bib93","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102277","type":"journal-article","article-title":"Adapted nano-carriers for gastrointestinal defense components: surface strategies and challenges","volume":"29","author":"Wang","year":"2020","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib94","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/antiox7050063","type":"journal-article","article-title":"Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for neuroprotection in Alzheimer\u2019s disease","volume":"7","author":"Pinto","year":"2018","journal-title":"Antioxidants"},{"key":"bmmabdc97bib95","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/jps.24044","type":"journal-article","article-title":"Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram","volume":"103","author":"Leyva-Gomez","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"bmmabdc97bib96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119693","type":"journal-article","article-title":"Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA","volume":"588","author":"Campani","year":"2020","journal-title":"Int.J. Pharm."},{"key":"bmmabdc97bib97","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2017.11.031","type":"journal-article","article-title":"Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: pharmacokinetic and teratogenic assessment","volume":"108","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmabdc97bib98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/17425247.2014.945416","type":"journal-article","article-title":"Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy","volume":"12","author":"Alam","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"bmmabdc97bib99","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","type":"journal-article","article-title":"Stimuli-responsive in situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control Release"},{"key":"bmmabdc97bib100","doi-asserted-by":"publisher","DOI":"10.1002\/marc.202000319","type":"journal-article","article-title":"Next-generation polymeric nanomedicines for oncology: perspectives and future directions","volume":"41","author":"Fletcher","year":"2020","journal-title":"Macromol. Rapid Commun."},{"key":"bmmabdc97bib101","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","type":"journal-article","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Control Release"},{"key":"bmmabdc97bib102","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/17425247.2018.1517745","type":"journal-article","article-title":"Advanced fabrication approaches to controlled delivery systems for epilepsy treatment","volume":"15","author":"van Tienderen","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"bmmabdc97bib103","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2019.109353","type":"journal-article","article-title":"Role of particle shape on efficient and organ-based drug delivery","volume":"122","author":"Nejati","year":"2020","journal-title":"Eur. Polym. J."},{"key":"bmmabdc97bib104","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jconrel.2020.03.051","type":"journal-article","article-title":"Stimuli-responsive nano-assemblies for remotely controlled drug delivery","volume":"322","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119778","type":"journal-article","article-title":"Biodegradable self-assembled nanoparticles of PEG-PLGA amphiphilic diblock copolymer as a promising stealth system for augmented vinpocetine brain delivery","volume":"588","author":"Ahmed","year":"2020","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib106","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13346-017-0438-8","type":"journal-article","article-title":"Intranasal delivery of alpha-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification","volume":"8","author":"Pan","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"bmmabdc97bib107","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jconrel.2020.02.020","type":"journal-article","article-title":"Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: development, characterization, in-vitro studies","volume":"164","author":"Pandey","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmabdc97bib108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119781","type":"journal-article","article-title":"Stimuli-responsive biodegradable polyurethane nano-constructs as a potential triggered drug delivery vehicle for cancer therapy","volume":"588","author":"Gajbhiye","year":"2020","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib109","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2020.06.009","type":"journal-article","article-title":"Design of amino acid-based self-assembled nano-drugs for therapeutic applications","volume":"326","author":"Vong","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib110","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejps.2018.01.028","type":"journal-article","article-title":"Lamotrigine loaded poly-varepsilon-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system","volume":"115","author":"Ammar","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"bmmabdc97bib111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijbiomac.2020.03.079","type":"journal-article","article-title":"Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer\u2019s disease","volume":"154","author":"Ji","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmabdc97bib112","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.nano.2018.01.019","type":"journal-article","article-title":"Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: a new anti-seizure strategy for temporal lobe epilepsy","volume":"14","author":"Cano","year":"2018","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib113","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2020.02.011","type":"journal-article","article-title":"Characterization of cationic bolaamphiphile vesicles for siRNA delivery into tumors and brain","volume":"20","author":"Kim","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"bmmabdc97bib114","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201808361","type":"journal-article","article-title":"Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke","volume":"31","author":"Lu","year":"2019","journal-title":"Adv. Mater."},{"key":"bmmabdc97bib115","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2017.05.028","type":"journal-article","article-title":"PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application","volume":"260","author":"Grossen","year":"2017","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib116","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/polym12020298","type":"journal-article","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming peg immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers"},{"key":"bmmabdc97bib117","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.2147\/ijn.s62263","type":"journal-article","article-title":"Enhanced brain delivery of lamotrigine with Pluronic((R)) P123-based nanocarrier","volume":"9","author":"Liu","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"bmmabdc97bib118","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biomaterials.2015.09.041","type":"journal-article","article-title":"Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery","volume":"74","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"bmmabdc97bib119","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901372","type":"journal-article","article-title":"Soft and ion-conducting materials in bioelectronics: from conducting polymers to hydrogels","volume":"9","author":"Jia","year":"2020","journal-title":"Adv. Healthcare Mater."},{"key":"bmmabdc97bib120","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s13311-016-0431-9","type":"journal-article","article-title":"Electroresponsive nanoparticles improve antiseizure effect of phenytoin in generalized tonic-clonic seizures","volume":"13","author":"Wang","year":"2016","journal-title":"Neurotherapeutics"},{"key":"bmmabdc97bib121","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801488","type":"journal-article","article-title":"Electrochemically controlled drug release from a conducting polymer hydrogel (PDMAAp\/PEDOT) for local therapy and bioelectronics","volume":"8","author":"Kleber","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"bmmabdc97bib122","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201701733","type":"journal-article","article-title":"Conjugated polymer for voltage-controlled release of molecules","volume":"29","author":"Liu","year":"2017","journal-title":"Adv. Mater."},{"key":"bmmabdc97bib123","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijbiomac.2020.01.147","type":"journal-article","article-title":"Synthesis and characterization of alginate and sterculia gum based hydrogel for brain drug delivery applications","volume":"148","author":"Singh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"bmmabdc97bib124","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","type":"journal-article","article-title":"Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies","volume":"270","author":"Pires","year":"2018","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib125","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3109\/03639041003758689","type":"journal-article","article-title":"Magnetic N-succinyl chitosan\/alginate beads for carbamazepine delivery","volume":"36","author":"Liu","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"bmmabdc97bib126","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jconrel.2012.05.038","type":"journal-article","article-title":"Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide","volume":"161","author":"Hsiao","year":"2012","journal-title":"J. Control. Release"},{"key":"bmmabdc97bib127","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.xphs.2018.04.007","type":"journal-article","article-title":"Superparamagnetic iron oxide-loaded lipid nanocarriers incorporated in thermosensitive in situ gel for magnetic brain targeting of clonazepam","volume":"107","author":"Abbas","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"bmmabdc97bib128","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2478\/acph-2020-0032","type":"journal-article","article-title":"Preparation, characterization, and in vivo pharmacokinetics of thermosensitive in situ nasal gel of donepezil hydrochloride","volume":"70","author":"Gu","year":"2020","journal-title":"Acta Pharm."},{"key":"bmmabdc97bib129","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102043","type":"journal-article","article-title":"An innovative in situ method of creating hybrid dendrimer nano-assembly: an efficient next generation dendritic platform for drug delivery","volume":"21","author":"Singh","year":"2019","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib130","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejps.2018.11.023","type":"journal-article","article-title":"RGD-modified polymer and liposome nanovehicles: recent research progress for drug delivery in cancer therapeutics","volume":"128","author":"Cheng","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"bmmabdc97bib131","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201700313","type":"journal-article","article-title":"Dendrimers as powerful building blocks in central nervous system disease: headed for successful nanomedicine","volume":"28","author":"Leiro","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"bmmabdc97bib132","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1021\/acs.molpharmaceut.6b00381","type":"journal-article","article-title":"Mechanism of PAMAM dendrimers internalization in hippocampal neurons","volume":"13","author":"Vidal","year":"2016","journal-title":"Mol. Pharm."},{"key":"bmmabdc97bib133","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2018.04.032","type":"journal-article","article-title":"PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: a biophysical and nanotoxicological characterization","volume":"544","author":"Igartua","year":"2018","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119701","type":"journal-article","article-title":"Carbon nanostructures: the drug and the delivery system for brain disorders","volume":"587","author":"Henna","year":"2020","journal-title":"Int. J. Pharm."},{"key":"bmmabdc97bib135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nano.2018.08.011","type":"journal-article","article-title":"L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles","volume":"15","author":"Gonzalez-Carter","year":"2019","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib136","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201801292","type":"journal-article","article-title":"Voltage-gated closed-loop control of small-molecule release from alumina-coated nanoporous gold thin film electrodes","volume":"28","author":"Li","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"bmmabdc97bib137","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700831","type":"journal-article","article-title":"Mesoporous silica and organosilica nanoparticles: physical chemistry, biosafety, delivery strategies, and biomedical applications","volume":"7","author":"Croissant","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"bmmabdc97bib138","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","type":"journal-article","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"bmmabdc97bib139","doi-asserted-by":"publisher","DOI":"10.1002\/ppsc.201900195","type":"journal-article","article-title":"Multidisciplinary role of mesoporous silica nanoparticles in brain regeneration and cancers: from crossing the blood\u2013brain barrier to treatment","volume":"36","author":"Mendiratta","year":"2019","journal-title":"Part. Part. Syst. Charact."},{"key":"bmmabdc97bib140","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.201800020","type":"journal-article","article-title":"Mesoporous silica nanoparticles for targeted and stimuli-responsive delivery of chemotherapeutics: a review","volume":"2","author":"Rahikkala","year":"2018","journal-title":"Adv. Biosyst."},{"key":"bmmabdc97bib141","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.apsb.2018.01.007","type":"journal-article","article-title":"Mesoporous silica nanoparticles for drug and gene delivery","volume":"8","author":"Zhou","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"bmmabdc97bib142","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10904-019-01245-6","type":"journal-article","article-title":"Biosynthesis, magnetic and cytotoxic studies of hematite nanoparticles","volume":"30","author":"Miri","year":"2019","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"bmmabdc97bib143","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.msec.2019.03.032","type":"journal-article","article-title":"Hybrid magneto-fluorescent nano-probe for live apoptotic cells monitoring at brain cerebral ischemia","volume":"100","author":"Mekawy","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"bmmabdc97bib144","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.colsurfb.2018.10.051","type":"journal-article","article-title":"Recent advances in magnetic fluid hyperthermia for cancer therapy","volume":"174","author":"Das","year":"2019","journal-title":"Colloids Surf. B"},{"key":"bmmabdc97bib145","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2019.109371","type":"journal-article","article-title":"Bio-inspired encapsulation and functionalization of iron oxide nanoparticles for biomedical applications","volume":"122","author":"Aisida","year":"2020","journal-title":"Eur. Polym. J."},{"key":"bmmabdc97bib146","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.arabjc.2018.04.013","type":"journal-article","article-title":"Green biosynthesis of superparamagnetic magnetite Fe3O4 nanoparticles and biomedical applications in targeted anticancer drug delivery system: a review","volume":"13","author":"Yew","year":"2020","journal-title":"Arab. J. Chem."},{"key":"bmmabdc97bib147","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2217\/nnm-2018-0021","type":"journal-article","article-title":"Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review","volume":"13","author":"Champagne","year":"2018","journal-title":"Nanomedicine"},{"key":"bmmabdc97bib148","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","type":"journal-article","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmabdc97bib149","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nano.2019.01.016","type":"journal-article","article-title":"The blood-brain barrier and beyond: nano-based neuropharmacology and the role of extracellular matrix","volume":"17","author":"Henrich-Noack","year":"2019","journal-title":"Nanomedicine"}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T13:25:53Z","timestamp":1765027553000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abdc97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":149,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,17]]},"published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/abdc97","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"value":"1748-6041","type":"print"},{"value":"1748-605X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"Recent advances on drug delivery nanocarriers for cerebral disorders","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2021 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2020-09-26","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2021-01-15","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2021-02-17","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}